ecteinascidin 743 has been researched along with Clear Cell Sarcoma of Soft Tissue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, N; Hamada, K; Imura, Y; Itoh, K; Kaneko, K; Myoui, A; Naka, N; Nakai, S; Nakai, T; Outani, H; Takenaka, S; Tamiya, H; Ueda, T; Yamada, S; Yasuda, N; Yoshikawa, H | 1 |
1 other study(ies) available for ecteinascidin 743 and Clear Cell Sarcoma of Soft Tissue
| Article | Year |
|---|---|
Trabectedin is a promising antitumor agent potentially inducing melanocytic differentiation for clear cell sarcoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dioxoles; Dose-Response Relationship, Drug; Humans; Melanocytes; Mice; Sarcoma, Clear Cell; Tetrahydroisoquinolines; Trabectedin; Xenograft Model Antitumor Assays | 2017 |